A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
PHASE1
The study will be conducted in participants with type1 diabetes on insulin ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects
PHASE1
The primary objective of this pilot study is to determine the within-subjec...
A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual Administration
PHASE3
This multicenter study in participants with HER2-positive eBC will investig...
Status
Completed
Location
State Inst N.N. Alexandrov Republican Scientific & Practical Centre of Oncology & Medical Radiology
A Study to Evaluate the Bioavailability, Safety and Tolerability of a Solid Dosage Formulation Relative to a Suspension of JNJ-54175446 in Healthy Male and Female Participants
PHASE1
The primary purpose of the study is to investigate the plasma pharmacokinet...